3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow SOFAR S.p.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesalazine Therapy in Patients With Irritable Bowel Syndrome Mesalazine, Placebo - Irritable Bowel Syndrome | Phase 3 | Completed | SOFAR S.p.A. | 187 | 2007-12-01 | 2013-07-26 |
| Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares mesalamine, placebo - Diverticular Disease | Phase 3 | Completed | SOFAR S.p.A. | 105 | 2005-10-01 | 2013-09-18 |
| A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome mesalazine, placebo - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Completed | SOFAR S.p.A. | 20 | 2004-09-01 | 2008-10-16 |
Irritable Bowel Syndrome (2) · Abdominal Pain (1) · Diverticular Diseases (1)
Mesalamine (3)
Italy (3)
Barbara Giovanni, Doctor (1) · Giovanni Barbara, MD (1) · Roberto Corinaldesi, MD (1) · Roberto Corinaldesi, Professor (1)